Healthcare provider profile · identity verified

Mitchell Lee Blom, D.O.

Family Practice · PELLA, IA · NPI 1558341917

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	563	143
Amlodipine Besylate	Amlodipine Besylate	482	125
Levothyroxine Sodium	Levothyroxine Sodium	458	110
Omeprazole	Omeprazole	334	92
Metoprolol Succinate	Metoprolol Succinate	319	82
Atorvastatin Calcium	Atorvastatin Calcium	316	79
Gabapentin	Gabapentin	287	60
Pantoprazole Sodium	Pantoprazole Sodium	286	63
Rosuvastatin Calcium	Rosuvastatin Calcium	279	84
Tamsulosin Hcl	Tamsulosin Hcl	265	65
Allopurinol	Allopurinol	250	49
Furosemide	Furosemide	246	53
Pravastatin Sodium	Pravastatin Sodium	237	60
Trazodone Hcl	Trazodone Hcl	225	40
Warfarin Sodium	Warfarin Sodium	213	37
Lisinopril	Lisinopril	209	58
Sertraline Hcl	Sertraline Hcl	200	45
Tramadol Hcl	Tramadol Hcl	186	45
Hydrochlorothiazide	Hydrochlorothiazide	180	45
Glimepiride	Glimepiride	176	44
Potassium Chloride	Potassium Chloride	171	32
Zolpidem Tartrate	Zolpidem Tartrate	170	31
Carvedilol	Carvedilol	163	38
Buspirone Hcl	Buspirone Hcl	150	24
Mirtazapine	Mirtazapine	133	24
Meloxicam	Meloxicam	124	35
Albuterol Sulfate Hfa	Albuterol Sulfate	121	34
Temazepam	Temazepam	117	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	23
Citalopram Hbr	Citalopram Hydrobromide	114	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	113	29
Ezetimibe	Ezetimibe	113	35
Finasteride	Finasteride	109	22
Metoprolol Tartrate	Metoprolol Tartrate	109	30
Metformin Hcl	Metformin Hcl	108	28
Eliquis	Apixaban	107	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	106	29
Lorazepam	Lorazepam	105	31
Duloxetine Hcl	Duloxetine Hcl	102	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	101	25
Azithromycin	Azithromycin	95	55
Escitalopram Oxalate	Escitalopram Oxalate	94	19
Telmisartan	Telmisartan	94	20
Clopidogrel	Clopidogrel Bisulfate	89	20
Simvastatin	Simvastatin	89	28
Xarelto	Rivaroxaban	79	14
Montelukast Sodium	Montelukast Sodium	78	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	76	16
Venlafaxine Hcl Er	Venlafaxine Hcl	76	17
Jardiance	Empagliflozin	75	17
Pregabalin	Pregabalin	73	suppressed
Bupropion Xl	Bupropion Hcl	71	11
Fluoxetine Hcl	Fluoxetine Hcl	69	14
Prednisone	Prednisone	69	40
Hydralazine Hcl	Hydralazine Hcl	68	13
Ropinirole Hcl	Ropinirole Hcl	65	15
Metformin Hcl Er	Metformin Hcl	64	20
Ozempic	Semaglutide	59	11
Fluticasone Propionate	Fluticasone Propionate	54	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	13
Clonazepam	Clonazepam	52	suppressed
Ketoconazole	Ketoconazole	48	23
Atenolol	Atenolol	47	12
Amitriptyline Hcl	Amitriptyline Hcl	46	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	46	suppressed
Bumetanide	Bumetanide	45	suppressed
Januvia	Sitagliptin Phosphate	45	11
Spironolactone	Spironolactone	45	suppressed
Valsartan	Valsartan	45	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	43	suppressed
Donepezil Hcl	Donepezil Hcl	42	suppressed
Lovastatin	Lovastatin	42	12
Levetiracetam	Levetiracetam	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	34
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	33
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Celecoxib	Celecoxib	37	suppressed
Colchicine	Colchicine	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	25
Fenofibrate	Fenofibrate,micronized	33	suppressed
Alprazolam	Alprazolam	31	suppressed
Baclofen	Baclofen	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	24
Fenofibrate	Fenofibrate	31	suppressed
Memantine Hcl Er	Memantine Hcl	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Amoxicillin	Amoxicillin	30	19
Colestipol Hcl	Colestipol Hcl	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Spiriva Handihaler	Tiotropium Bromide	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Alendronate Sodium	Alendronate Sodium	28	12
Benazepril Hcl	Benazepril Hcl	28	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	28	suppressed
Nabumetone	Nabumetone	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	12
Memantine Hcl	Memantine Hcl	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Cephalexin	Cephalexin	23	16
Famotidine	Famotidine	23	suppressed
Promethazine Hcl	Promethazine Hcl	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Methadone Hcl	Methadone Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Terbinafine Hcl	Terbinafine Hcl	20	11
Ery-Tab	Erythromycin Base	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	15
Terazosin Hcl	Terazosin Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Fluconazole	Fluconazole	18	13
Nitroglycerin	Nitroglycerin	18	11
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Procto-Med Hc	Hydrocortisone	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Primidone	Primidone	16	suppressed
Minoxidil	Minoxidil	15	suppressed
Naproxen	Naproxen	15	suppressed
Propafenone Hcl	Propafenone Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Diclofenac Potassium	Diclofenac Potassium	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lactulose	Lactulose	11	suppressed
Oxazepam	Oxazepam	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error